HighMark Wealth Management’s Apyx Medical APYX Stock Holding History

HighMark Wealth Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.4K	Hold	5,000	–	–	0.01%	232
2025 Q4	$17.5K	Hold	5,000	–	–	0.01%	255
2025 Q3	$10.7K	Hold	5,000	–	–	﹤0.01%	293
2025 Q2	$11.3K	Hold	5,000	–	–	0.01%	294
2025 Q1	$6.85K	Hold	5,000	–	–	﹤0.01%	331
2024 Q4	$7.9K	Hold	5,000	–	–	﹤0.01%	327
2024 Q3	$6.2K	Hold	5,000	–	–	﹤0.01%	376
2024 Q2	$6.7K	Hold	5,000	–	–	﹤0.01%	345
2024 Q1	$6.8K	Hold	5,000	–	–	﹤0.01%	340
2023 Q4	$13.1K	Buy	+5,000	New	+$12.1K	0.01%	236

Other funds holding APYX

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Commonwealth Equity Services

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

SEI Investments

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return